Literature DB >> 25457029

Important outcome predictors showed greater baseline heterogeneity than age in two systematic reviews.

Laura Clark1, Caroline Fairhurst2, Elizabeth Cook2, David J Torgerson2.   

Abstract

OBJECTIVES: An unknown number of randomized controlled trials (RCTs) have their treatment allocation subverted. If such trials are included in systematic reviews, biased results may be used to change policy. To assess whether a systematic review contains subverted trials, a meta-analysis of group differences regarding a baseline variable can be undertaken. In this article, the performance of age with another prognostic variable in detecting selection bias within systematic reviews is compared. STUDY DESIGN AND
SETTING: Two Cochrane systematic reviews, one of low back pain and one of hip protectors for fracture prevention, were identified. The component RCT texts were obtained, and data were extracted on age, baseline back pain score (low back pain review), and baseline body mass (hip protector review). In this exemplar, we tested for baseline heterogeneity with a fixed-effects meta-analysis.
RESULTS: Heterogeneity in age between the intervention and control groups was found. The observed heterogeneity increased with baseline back pain and body mass relative to age in each review.
CONCLUSION: We found that covariates predictive of outcome demonstrate greater heterogeneity than age. However, there were fewer missing data relating to age. Reviewers should consider using age and another prognostic covariate in baseline meta-analyses to check the validity of their results.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bias; Heterogeneity; Meta-analysis; Meta-regression; RCTs; Systematic review

Mesh:

Year:  2014        PMID: 25457029     DOI: 10.1016/j.jclinepi.2014.09.023

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  4 in total

1.  An approach to exploring patterns of imbalance and potential missingness in reports of the randomized baseline values for primary outcomes measurable at baseline in randomized controlled trials for meta-analyses.

Authors:  Eun-Gee Park; Seokyung Hahn
Journal:  BMC Med Res Methodol       Date:  2022-05-28       Impact factor: 4.612

2.  Cochrane: the unfinished symphony of research synthesis.

Authors:  Ian Roberts; Katharine Ker
Journal:  Syst Rev       Date:  2016-07-14

3.  Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta-epidemiological study of randomized trials.

Authors:  Tessa A Hulshof; Sytse U Zuidema; Peter J K van Meer; Christine C Gispen-de Wied; Hendrika J Luijendijk
Journal:  Int J Methods Psychiatr Res       Date:  2018-12-04       Impact factor: 4.035

4.  Assessing risk of bias: a proposal for a unified framework for observational studies and randomized trials.

Authors:  Hendrika J Luijendijk; Matthew J Page; Huibert Burger; Xander Koolman
Journal:  BMC Med Res Methodol       Date:  2020-09-23       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.